Multi-Ingredient Pre-Workouts and High-Intensity Functional Training: What a Controlled Trial Reveals About Acute Muscle Perfusion, Metabolism, and Perceived Effort

Table of Contents

1. Key Highlights:
2. Introduction
3. Why multi-ingredient pre-workouts are appealing for HIFT
4. The study at a glance: design, participants, and measurements
5. Main findings: what changed and what did not
6. Interpreting the acute increase in quadriceps CSA
7. Why systemic metabolic and perceptual markers remained unchanged
8. How these findings align with prior research
9. Practical implications for athletes, coaches, and sports nutritionists
10. Limitations that affect interpretation and application
11. What the study suggests about programming and future research
12. Practical checklist for athletes and coaches considering a MIPS for HIFT
13. FAQ

Key Highlights:

• A single serving of a commercially available multi-ingredient pre-workout supplement (MIPS) produced larger acute increases in quadriceps cross-sectional area (CSA) after both 5‑ and 15‑minute AMRAP HIFT workouts, consistent with greater transient muscle perfusion.
• The supplement did not change post-exercise heart rate, blood lactate, energy expenditure, respiratory exchange, or perceived exertion and fatigue; observed performance benefits likely derive from task-specific efficiency rather than increased global physiological strain.
• Men and women showed expected physiological differences (higher lactate, CO2, oxygen consumption, and caloric cost in men), but the supplement’s acute effect on muscle CSA applied across sexes.

Introduction

Multi-ingredient pre-workout supplements are a staple for many athletes. They bundle stimulants, nitric oxide precursors, osmolytes, and buffering agents into a single dose intended to sharpen focus and extend work capacity. High-intensity functional training (HIFT) — typified by CrossFit-style AMRAP workouts — demands repeated bursts of strength, power, and aerobic effort inside a short time window. Those dual demands make HIFT a logical setting to test whether a pre-workout can do more than just make an athlete feel energized.

A recent double-blind, randomized crossover trial examined acute physiological and perceptual responses to one commercially available MIPS taken before two versions of the same AMRAP-style HIFT circuit: a short, high-intensity 5‑minute bout and a longer 15‑minute bout. The top-line result: the supplement produced larger immediate increases in quadriceps muscle size, measured by ultrasound, without producing measurable changes in lactate, heart rate, oxygen consumption, or perceived effort. That pattern points to a subtler mechanism—transient changes in muscle fluid and nutrient delivery—rather than broad metabolic amplification.

This article synthesizes the trial’s methods and findings, situates them among existing evidence on MIPS and exercise physiology, examines practical implications for athletes and coaches, and identifies the research steps needed to turn acute observations into reliable guidance.

What follows is a detailed, actionable review intended for athletes, coaches, sports dietitians, and training professionals who weigh the costs and benefits of pre-workout supplementation for HIFT-style training.

Why multi-ingredient pre-workouts are appealing for HIFT

MIPS formulations combine ingredients that operate through different mechanisms. Typical components include caffeine (alertness and central drive), beta-alanine (intracellular buffering via carnosine), creatine (short-term phosphagen availability), and nitric oxide (NO) precursors such as L-citrulline or dietary nitrate (beetroot and spinach extracts) that can augment vasodilation and blood flow. Some products also contain osmolytes — compounds that alter intracellular and extracellular water dynamics — and nootropics intended to sharpen cognition.

Each ingredient has an evidence base for specific outcomes:

• Caffeine reliably improves alertness and performance in many exercise contexts after a single dose.
• Beta-alanine and creatine typically require loading to show maximal effects, but some acute benefits can appear depending on context and dose.
• Nitric oxide precursors and dietary nitrates show acute ergogenic effects for sustained high‑intensity and repeated sprint efforts by improving muscle blood flow and possibly mitochondrial efficiency.
• Osmolytes and other compounds that affect cellular hydration may influence transient muscle “pump” and nutrient delivery.

HIFT workouts require rapid transitions across strength, gymnastic, and metabolic tasks. Performance hinges not only on peak force production but on sustaining effort and minimizing unplanned breaks. A supplement that transiently improves blood flow and intracellular water content could plausibly support continuous effort—particularly across longer AMRAPs or continuous rowing segments—without necessarily changing systemic measures like peak heart rate or lactate if participants are already near physiological limits.

The study at a glance: design, participants, and measurements

The trial used a double-blind, placebo-controlled, crossover design. Each participant completed four experimental sessions over consecutive weeks: 5-minute AMRAP with supplement, 5-minute AMRAP with placebo, 15-minute AMRAP with supplement, and 15-minute AMRAP with placebo. Sessions were counterbalanced and randomized.

Participants

• Twenty-three HIFT-experienced adults (men and women with at least two years of HIFT experience) were enrolled; all completed the protocol except one participant who withdrew for scheduling reasons.
• Participants were medically screened and free from performance-enhancing drugs or interfering medications.

Supplement and placebo

• The supplement was a commercially available MIPS chosen because it contained well-researched ingredients at efficacious doses (including L-citrulline and concentrated plant nitrates, caffeine, beta-alanine, creatine, osmolytes, and nootropics).
• The placebo was a flavored, zero-calorie water enhancer mixed to match taste and appearance; both drinks were consumed from opaque bottles with nose clips to limit sensory cues.

Key measurements

• Ultrasound was used to measure rectus femoris (RF) and vastus lateralis (VL) cross-sectional area (CSA) and echo intensity (EI) at pre-exercise and post-exercise. CSA increases were interpreted as transient increases in muscle size consistent with perfusion and fluid shifts.
• Heart rate was monitored continuously and reported as absolute beats per minute and percent of age-predicted maximum.
• Blood lactate was measured at pre-exercise, immediately post-exercise, and 5 minutes post-exercise.
• Energy expenditure and respiratory variables (VO2, VCO2, RQ, METs) were assessed in a short post-exercise window (5–10 minutes post-exercise) using a metabolic cart.
• Perception scales included a modified RPE (0–10) and visual analog scales for focus, energy, and fatigue.

Testing protocol essentials

• Participants arrived 2–3 hours postprandial and avoided vigorous activity for 48 hours prior.
• After pre-test measures participants consumed supplement or placebo, rested 40 minutes, completed a standardized warm-up, then performed the assigned AMRAP.
• Post-exercise measurements were collected immediately and in the early recovery phase.

The crossover design ensured each person served as their own control, strengthening inferences about acute supplement effects while maintaining relatively high ecological validity for real-world HIFT sessions.

Main findings: what changed and what did not

Muscle morphology

• Both RF and VL CSA increased from pre- to post-exercise under all conditions, consistent with the expected acute pump effect after high-intensity exercise.
• The supplement produced greater CSA increases than placebo for the rectus femoris in both the 5‑ and 15‑minute AMRAPs (mean differences +1.22 cm^2 and +1.43 cm^2, respectively). For vastus lateralis the supplement effect was significant only after the 15‑minute bout (+4.63 cm^2).
• Echo intensity (EI), a marker that can rise with edema or early damage and fall with improved intracellular water or perfusion, did not differ between conditions.

Heart rate and lactate

• Heart rate rose substantially immediately after both workouts and remained elevated at 5 minutes post-exercise; responses were typical for HIFT and did not differ between supplement and placebo.
• Blood lactate increased markedly after exercise for all conditions and time points; men had modestly higher lactate concentrations overall. The supplement did not attenuate lactate elevations.

Energy expenditure and respiratory variables

• Post-exercise VO2, METs, and kilocalorie expenditure increased compared to pre-exercise baseline, consistent with excess post-exercise oxygen consumption (EPOC). No differences emerged between supplement and placebo.
• Men showed higher VO2 and VCO2 during recovery after the 15-minute bout, reflecting greater lean mass and different substrate utilization.

Perception of effort and fatigue

• RPE and subjective fatigue rose substantially from pre- to post-exercise for both workouts regardless of supplement condition. Men reported slightly higher RPE values than women.
• Subjective measures of “energy” and “focus” did not change in a consistent way and did not differ with supplementation.

Sex differences

• Men had greater VL CSA, higher lactate, greater VCO2, higher RQ, and greater caloric expenditure than women across conditions. These sex differences aligned with known differences in lean mass and metabolic response to high-intensity exercise.

Collectively these results point to an acute, localized effect of the MIPS on quadriceps size—most consistent with transient increases in muscle perfusion—without altering whole-body metabolic stress or subjective effort at the measured recovery time points.

Interpreting the acute increase in quadriceps CSA

Ultrasound-based increases in CSA after exercise capture a combination of factors: increased blood volume within the muscle, shifts in intracellular and extracellular water, and transient swelling of muscle fibers (cell swelling). In this trial the supplement produced a larger CSA increase than placebo. Several plausible mechanisms explain that observation.

Nitric oxide precursors

• Ingredients such as L-citrulline and dietary nitrates convert to nitric oxide or enhance arginine availability, promoting vasodilation. Greater local vasodilation during and immediately after exercise could increase capillary blood volume and augment the visible muscle “pump,” thus increasing CSA.
• Prior research shows acute ingestion of citrulline or nitrate-rich beetroot can increase blood flow and improve some aspects of high-intensity performance, particularly during sustained efforts.

Osmolytes and fluid shifts

• Osmotically active compounds in some formulations can alter plasma and intracellular water distribution, encouraging cell swelling. Cell swelling has anabolic signaling implications in chronic contexts and may enhance muscle work capacity acutely by improving the cellular environment for contraction.

Task-specific perfusion demands

• The supplement’s effect was present for rectus femoris after both durations and for vastus lateralis after the longer bout only. That pattern suggests a relationship with the duration and continuity of effort: longer continuous tasks may magnify the perfusion advantage.

Why echo intensity didn’t change

• Echo intensity is sensitive to imaging settings and tissue contrast and can detect edema or early damage when increased. The absence of EI change does not necessarily negate a perfusion effect; variability in depth and contrast across participants or the timing of imaging could obscure subtle EI shifts that correspond to perfusion.

Practical takeaway

• Increased CSA after a single dose of MIPS most plausibly reflects improved muscle perfusion and transient fluid shifts rather than structural muscle change. These shifts can support nutrient and oxygen delivery during continuous efforts, which may be particularly advantageous for the steady-state or continuous segments inside a HIFT workout.

Why systemic metabolic and perceptual markers remained unchanged

A core finding is that systemic markers—heart rate, blood lactate, VO2 in the immediate recovery window, and subjective RPE—showed no difference between supplement and placebo despite greater muscle CSA. Several factors explain that dissociation.

Near-maximal physiological ceiling

• HIFT workouts push participants close to maximal cardiovascular and metabolic capacity. When heart rate and lactate are already near their physiological maxima, a supplement that marginally increases blood flow will not further elevate these global markers. In other words, the body’s overall stress was already at or near ceiling; localized perfusion changes can still occur without shifting whole-body outputs.

AMRAP design and variable work output

• AMRAP prescriptions leave total work output autoregulated. If a supplement enables an athlete to do more work, systemic metabolic markers may increase proportionally and thus mask any metabolic attenuation. The trial observed that the same cohort previously performed more work on some task segments with the supplement, which could offset possible reductions in metabolite accumulation.

Timing of measurements

• The trial measured metabolic variables predominantly in a short recovery window (5–10 minutes after exercise). Acute changes that occur during exercise or earlier in recovery may have been missed because of logistical demands of HIFT testing (moving participants from the workout area to metabolic carts and obtaining blood samples). Some ingredient effects, especially those on buffering or intracellular mechanisms, might emerge later in recovery or after chronic use.

Ingredient-specific dynamics

• Ingredients that acutely stimulate perfusion (nitrates, citrulline) affect blood flow rapidly and can influence local oxygen delivery. Ingredients that buffer acid (beta-alanine) or increase intracellular phosphagen stores (creatine) often require chronic supplementation to reach full effectiveness. Caffeine affects central drive and perceived exertion, but its effect on HR and lactate can be minimal during near-maximal efforts.

Perceptual scaling and expectation

• Perceived energy and focus are subjective and influenced by expectations and personality. When exercise imposes strong physiological strain, subjective signals related to effort and fatigue tend to converge toward the body’s physical limits, reducing sensitivity to mild ergogenic effects of a supplement.

Net interpretation

• The supplement’s acute advantage appears to be task-specific and localized rather than a broad systemic change. That local advantage may translate into performance gains during continuous actions within a HIFT session without altering classic recovery or stress markers measured in a short post-exercise window.

How these findings align with prior research

Prior MIPS studies report mixed outcomes depending on exercise mode, duration, and measurement timing:

• Resistance training studies have documented greater training volume and power outputs after single doses of certain MIPS, sometimes without different RPE.
• Time-to-fatigue studies and endurance tests often show benefits with nitrate-rich or caffeinated formulations, particularly when exercise intensity is submaximal or sustained.
• HIFT-specific literature is limited but indicates common physiological responses are high heart rate and lactate comparable to maximal aerobic or Wingate tests.

This trial complements prior work by inserting non-invasive muscle morphology measures into the acute HIFT context. It gives mechanistic plausibility—enhanced local perfusion—that helps explain why MIPS sometimes improve work capacity in continuous effort tasks even when global measures remain unchanged.

Practical implications for athletes, coaches, and sports nutritionists

When to consider a MIPS for HIFT

• Favor MIPS for workouts that include prolonged continuous efforts (rowing, assault bike segments, or long, nonstop movement sets) where improved muscle perfusion and nutrient delivery could support sustained force production.
• Expect less acute benefit for very short maximal-effort workouts where anaerobic glycolysis and neuromuscular factors dominate and perfusion advantages have limited time to matter.

Timing and administration

• The trial used a 40-minute rest period between ingestion and exercise to allow absorption of NO precursors and other active compounds. Matching that timing is prudent when aiming for acute circulatory effects.
• Consume the supplement in a setting similar to competition if the goal is to match expectations and avoid novel sensory cues.

Task-specific examples

• A CrossFit athlete aiming to improve performance in a 15‑minute AMRAP that starts with a 500-m row followed by thrusters might benefit from a MIPS taken 30–45 minutes pre-workout. Improved perfusion during rowing could reduce the need for early pace reduction and preserve form for the thruster set.
• For interval sessions comprising short, repeated maximal efforts (e.g., 30-s all-out sprints with long rests), the supplement might have limited acute benefit but could support training adherence or perceived readiness through caffeine’s central effects.

Sex considerations

• Men show higher lactate, CO2 output, and VO2 post-exercise due to greater lean mass and metabolic demand. The supplement’s acute increase in muscle CSA was seen across sexes, suggesting perfusion effects are not sex-specific. Still, coaches should monitor individual responses when prescribing supplements.

Safety, dosing, and regulatory notes

• Ingredients contained in MIPS often include caffeine and other stimulants. Adverse effects (jitters, tachycardia, sleep disturbance) can occur; dosing should be conservative for novices and low caffeine-tolerant individuals.
• Check supplement labels for banned substances if competing in organizations with strict anti-doping rules.
• Chronic supplementation effects (e.g., for beta-alanine and creatine) may be additive; consider combined acute and chronic strategies depending on training cycles.

Managing expectations

• A single dose of MIPS is unlikely to dramatically change whole-body metabolic responses during near-maximal HIFT. Expect more modest, task-specific benefits and monitor changes in actual work output rather than relying on heart rate or lactate as the only indicators.

Cost–benefit and real-world adoption

• Many HIFT athletes already use supplements. When the goal is to eke out marginal gains in continuous-effort elements of competition-style WODs, a trialed, well-dosed MIPS may be justified. For casual trainees, the marginal gains may not offset cost and potential side effects.

Limitations that affect interpretation and application

Measurement timing and logistics

• Metabolic and heart rate measures were captured mainly after exercise, not during. Given the multimodal nature of HIFT, continuous metabolic measurement during workouts is technically challenging and was not feasible in this protocol. Early recovery measurements capture EPOC rather than exercise physiology in real time.

Ultrasound proxies and perfusion

• Ultrasound CSA is an indirect proxy for perfusion. Doppler ultrasound or direct blood flow measures would more conclusively demonstrate enhanced perfusion. The absence of echo intensity changes complicates interpretation, though EI variability may reflect imaging constraints.

Placebo and blinding concerns

• Despite efforts to mask sensory cues, ingredients like caffeine and beta-alanine produce recognizable sensations that can partially unblind participants. The placebo did not contain these stimulants, and formal blinding tests were not reported.

Population generalizability

• Participants were experienced HIFT trainees. Findings may not generalize to untrained individuals, endurance athletes, or elite competitive athletes with different physiological baselines.

Dose and formulation specificity

• Results reflect a single commercially available formulation. Different brands or dosages, especially those with different nitrate or stimulant contents, could produce different outcomes.

Single-dose, acute focus

• Many MIPS ingredients show maximal ergogenicity after chronic loading (beta-alanine, creatine). This trial does not address whether repeated dosing improves recovery or cumulative performance over training cycles.

Funding and potential biases

• The study received funding from the supplement manufacturer. Authors declared no conflicts of interest, but readers should weigh sponsorship when interpreting nuanced findings.

What the study suggests about programming and future research

Programming guidance

• Use MIPS strategically: prioritize sessions with long continuous efforts where a perfusion advantage could meaningfully affect pacing and break frequency.
• Track objective outputs (e.g., split times, total repetitions, meters rowed) to detect supplement effects rather than relying solely on perceived effort or heart rate.
• Consider combined strategies: chronic supplementation for creatine and beta-alanine for training phases aimed at strength and buffering capacity, paired with acute nitrates and caffeine on key sessions.

Research priorities

• Direct perfusion measures during and immediately after HIFT using advanced Doppler or near-infrared spectroscopy could validate CSA-based inferences.
• Longer post-exercise monitoring for metabolic markers would clarify whether MIPS affects recovery beyond the 10-minute window.
• Chronic supplementation studies that combine acute pre-workout dosing with loading strategies for buffering and creatine would give a fuller picture of practical benefit.
• Stratified trials that classify HIFT athletes by training status, relative strength, and event-specific demands will improve applicability.
• Taste and placebo-control methods that better mask stimulant sensations would strengthen future acute trials.

Practical checklist for athletes and coaches considering a MIPS for HIFT

• Confirm absence of banned substances for your sport or event before using any supplement.
• Trial the supplement well before a competition day to observe individual tolerance (caffeine sensitivity, paresthesia from beta-alanine).
• Time ingestion about 30–45 minutes before workouts that include continuous elements; adjust based on personal digestion and stimulant sensitivity.
• Track objective performance measures (work completed, split times) rather than subjective feelings alone.
• Monitor hydration and sleep; stimulants can impair sleep if taken late in the day and osmolyte-driven fluid shifts require adequate hydration.
• For athletes already using creatine or beta-alanine, maintain loading/maintenance strategies rather than expecting immediate additive benefits from a single pre-workout serving.

FAQ

Q: Will taking a MIPS guarantee better performance in a CrossFit workout? A: No single product guarantees better performance. This trial shows acute increases in quadriceps size consistent with enhanced perfusion, which may support continuous-effort segments and help athletes perform slightly more work or maintain pace. Benefits depend on workout structure, individual tolerance, and task specificity. Expect modest, context-dependent advantages rather than sweeping improvements.

Q: Does the supplement reduce lactate accumulation or perceived exertion? A: The study did not find reductions in blood lactate, heart rate, VO2, or perceived exertion in the early recovery window. If supplementation enabled athletes to do more work, systemic markers could remain similar because greater output offsets any metabolic modulation. Beta-alanine and creatine often require chronic dosing to affect lactate dynamics meaningfully.

Q: Is the increase in muscle CSA meaningful for long-term gains? A: The CSA change observed is acute and reflects transient fluid shifts and perfusion rather than structural hypertrophy. While repeated bouts of enhanced nutrient delivery might support training adaptations over time, the study does not show long-term hypertrophic outcomes from a single dose.

Q: Are men and women affected differently by the supplement? A: Men exhibited higher lactate, CO2 output, and oxygen consumption after exercise, consistent with greater lean mass and metabolic demand. The supplement’s immediate effect on quadriceps CSA was observed across sexes, indicating perfusion-related changes are not sex-limited in the acute setting.

Q: Should athletes avoid MIPS before short, all-out efforts? A: Short maximal efforts rely heavily on phosphagen and neuromuscular capacity. Acute perfusion advantages likely make less difference during brief sprints or sub-30-second all-outs. Caffeine may still provide central benefits, but perfusion-related ingredients are less likely to confer meaningful gains for very brief tasks.

Q: How should an athlete test whether a MIPS helps them? A: Run a simple, controlled trial: pick a representative workout with continuous elements, perform it multiple times under consistent conditions (same time of day, nutrition, sleep), and compare objective outputs (reps, time) on supplement versus placebo days, ideally separated by adequate washout. Track side effects and subjective readiness as well.

Q: Are there safety concerns with MIPS? A: Common side effects include jitteriness, gastrointestinal upset, elevated heart rate, and sleep disruption from stimulants. People with cardiovascular conditions or sensitivity to stimulants should consult a healthcare professional before use. Always read labels for total caffeine and review ingredient lists for banned substances if competing.

Q: Could chronic use of the same MIPS produce larger or different effects? A: Yes. Ingredients like creatine and beta-alanine show greater effectiveness after loading and maintenance phases. Chronic nitrate supplementation may also produce different adaptations over time. Long-term studies combining acute pre-workout dosing with chronic supplementation are needed.

Q: Does the funding source undermine the study findings? A: The trial received funding from the supplement manufacturer, and authors reported no conflicts of interest. Funding does not invalidate findings but underscores the importance of external replication and transparency in methodology. Readers should weigh results alongside other independent studies.

Q: What should researchers study next? A: Key priorities include direct blood flow measures during HIFT, longer-term recovery tracking, chronic supplementation protocols, improved blinding methods, and trials that stratify athletes by training status and workout type. Those steps will clarify mechanisms and practical utility.

The trial offers a measured finding: a single pre-workout serving can increase immediate quadriceps size after HIFT, likely reflecting increased perfusion and transient fluid shifts. That local effect helps explain previously reported task-specific performance gains without necessitating changes in whole-body metabolic markers or subjective effort. Coaches and athletes should weigh these nuanced benefits against costs, individual tolerance, and workout demands when deciding whether to include a MIPS in their pre-workout routine.